197 related articles for article (PubMed ID: 8529132)
1. Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck.
Gapany M; Faust RA; Tawfic S; Davis A; Adams GL; Ahmed K
Mol Med; 1995 Sep; 1(6):659-66. PubMed ID: 8529132
[TBL] [Abstract][Full Text] [Related]
2. Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation.
Faust RA; Gapany M; Tristani P; Davis A; Adams GL; Ahmed K
Cancer Lett; 1996 Mar; 101(1):31-5. PubMed ID: 8625279
[TBL] [Abstract][Full Text] [Related]
3. Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells.
Faust RA; Niehans G; Gapany M; Hoistad D; Knapp D; Cherwitz D; Davis A; Adams GL; Ahmed K
Int J Biochem Cell Biol; 1999 Sep; 31(9):941-9. PubMed ID: 10533285
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro.
Faust RA; Tawfic S; Davis AT; Bubash LA; Ahmed K
Head Neck; 2000 Jul; 22(4):341-6. PubMed ID: 10862016
[TBL] [Abstract][Full Text] [Related]
5. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck.
Hoellein A; Pickhard A; von Keitz F; Schoeffmann S; Piontek G; Rudelius M; Baumgart A; Wagenpfeil S; Peschel C; Dechow T; Bier H; Keller U
Oncotarget; 2011 Aug; 2(8):599-609. PubMed ID: 21865609
[TBL] [Abstract][Full Text] [Related]
6. Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck.
McCaffery JD; Gapany M; Faust RA; Davis AT; Adams GL; Ahmed K
Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):283-8. PubMed ID: 9076234
[TBL] [Abstract][Full Text] [Related]
7. Association between phosphorylated AMP-activated protein kinase and acetyl-CoA carboxylase expression and outcome in patients with squamous cell carcinoma of the head and neck.
Su YW; Lin YH; Pai MH; Lo AC; Lee YC; Fang IC; Lin J; Hsieh RK; Chang YF; Chen CL
PLoS One; 2014; 9(4):e96183. PubMed ID: 24769813
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
10. Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.
Younes MN; Yigitbasi OG; Yazici YD; Jasser SA; Bucana CD; El-Naggar AK; Mills GB; Myers JN
Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):15-23. PubMed ID: 17224516
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase CK2 signal in neoplasia.
Tawfic S; Yu S; Wang H; Faust R; Davis A; Ahmed K
Histol Histopathol; 2001 Apr; 16(2):573-82. PubMed ID: 11332713
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis.
Logullo AF; Nonogaki S; Miguel RE; Kowalski LP; Nishimoto IN; Pasini FS; Federico MH; Brentani RR; Brentani MM
J Oral Pathol Med; 2003 Mar; 32(3):139-45. PubMed ID: 12581383
[TBL] [Abstract][Full Text] [Related]
13. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
14. Silmitasertib, a casein kinase 2 inhibitor, induces massive lipid droplet accumulation and nonapoptotic cell death in head and neck cancer cells.
Su YW; Huang WY; Lin HC; Liao PN; Lin CY; Lin XY; Huang SH; Chen YT; Wu PS
J Oral Pathol Med; 2023 Mar; 52(3):245-254. PubMed ID: 36273268
[TBL] [Abstract][Full Text] [Related]
15. Expression of a novel marker, Ubc9, in squamous cell carcinoma of the head and neck.
Ronen O; Malone JP; Kay P; Bivens C; Hall K; Paruchuri LP; Mo YY; Robbins KT; Ran S
Head Neck; 2009 Jul; 31(7):845-55. PubMed ID: 19309722
[TBL] [Abstract][Full Text] [Related]
16. High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.
Erpolat OP; Gocun PU; Akmansu M; Karakus E; Akyol G
Strahlenther Onkol; 2012 Mar; 188(3):248-54. PubMed ID: 22311150
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of ERCC1 protein expression in resected oropharynx and oral cavity cancer.
An HJ; Jo H; Jung CK; Kang JH; Kim MS; Sun DI; Cho KJ; Cho JH; Won HS; Sun S; Ko YH
Pathol Res Pract; 2017 Aug; 213(8):949-955. PubMed ID: 28645807
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
19. Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
Kreycy N; Gotzian C; Fleming T; Flechtenmacher C; Grabe N; Plinkert P; Hess J; Zaoui K
BMC Cancer; 2017 May; 17(1):382. PubMed ID: 28549423
[TBL] [Abstract][Full Text] [Related]
20. Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation.
Allende JE; Allende CC
FASEB J; 1995 Mar; 9(5):313-23. PubMed ID: 7896000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
